Viewing Study NCT02718833


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-03-02 @ 5:34 PM
Study NCT ID: NCT02718833
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-09
First Post: 2016-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
Sponsor: Massachusetts General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapse View
None Multiple Myeloma View